title: Bacterial meningitis in the United States, 1998-2007.
abstract: BACKGROUND
  The rate of bacterial meningitis declined by 55% in the United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was introduced. More recent prevention measures such as the pneumococcal conjugate vaccine and universal screening of pregnant women for group B streptococcus (GBS) have further changed the epidemiology of bacterial meningitis.
  
  
  METHODS
  We analyzed data on cases of bacterial meningitis reported among residents in eight surveillance areas of the Emerging Infections Programs Network, consisting of approximately 17.4 million persons, during 1998-2007. We defined bacterial meningitis as the presence of H. influenzae, Streptococcus pneumoniae, GBS, Listeria monocytogenes, or Neisseria meningitidis in cerebrospinal fluid or other normally sterile site in association with a clinical diagnosis of meningitis.
  
  
  RESULTS
  We identified 3188 patients with bacterial meningitis; of 3155 patients for whom outcome data were available, 466 (14.8%) died. The incidence of meningitis changed by -31% (95% confidence interval [CI], -33 to -29) during the surveillance period, from 2.00 cases per 100,000 population (95% CI, 1.85 to 2.15) in 1998-1999 to 1.38 cases per 100,000 population (95% CI 1.27 to 1.50) in 2006-2007. The median age of patients increased from 30.3 years in 1998-1999 to 41.9 years in 2006-2007 (P<0.001 by the Wilcoxon rank-sum test). The case fatality rate did not change significantly: it was 15.7% in 1998-1999 and 14.3% in 2006-2007 (P=0.50). Of the 1670 cases reported during 2003-2007, S. pneumoniae was the predominant infective species (58.0%), followed by GBS (18.1%), N. meningitidis (13.9%), H. influenzae (6.7%), and L. monocytogenes (3.4%). An estimated 4100 cases and 500 deaths from bacterial meningitis occurred annually in the United States during 2003-2007.
  
  
  CONCLUSIONS
  The rates of bacterial meningitis have decreased since 1998, but the disease still often results in death. With the success of pneumococcal and Hib conjugate vaccines in reducing the risk of meningitis among young children, the burden of bacterial meningitis is now borne more by older adults. (Funded by the Emerging Infections Programs, Centers for Disease Control and Prevention.).
authors: Centers for Disease Control and Prevention, Atlanta, USA. mthigpen@cdc.gov
authors: Michael C
authors: MC
authors: Thigpen
authors: Cynthia G
authors: CG
authors: Whitney
authors: Nancy E
authors: NE
authors: Messonnier
authors: Elizabeth R
authors: ER
authors: Zell
authors: Ruth
authors: R
authors: Lynfield
authors: James L
authors: JL
authors: Hadler
authors: Lee H
authors: LH
authors: Harrison
authors: Monica M
authors: MM
authors: Farley
authors: Arthur
authors: A
authors: Reingold
authors: Nancy M
authors: NM
authors: Bennett
authors: Allen S
authors: AS
authors: Craig
authors: William
authors: W
authors: Schaffner
authors: Ann
authors: A
authors: Thomas
authors: Melissa M
authors: MM
authors: Lewis
authors: Elaine
authors: E
authors: Scallan
authors: Anne
authors: A
authors: Schuchat